These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 127806)
21. Minimally invasive (13)C-breath test to examine phenylalanine metabolism in children with phenylketonuria. Turki A; Murthy G; Ueda K; Cheng B; Giezen A; Stockler-Ipsiroglu S; Elango R Mol Genet Metab; 2015; 115(2-3):78-83. PubMed ID: 25943030 [TBL] [Abstract][Full Text] [Related]
22. Phenylalanine hydroxylase expression in liver of a fetus with phenylketonuria. Ledley FD; Koch R; Jew K; Beaudet A; O'Brien WE; Bartos DP; Woo SL J Pediatr; 1988 Sep; 113(3):463-8. PubMed ID: 2900886 [TBL] [Abstract][Full Text] [Related]
23. Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine. Loo YH; Scotto J; Wisniewski HM Adv Exp Med Biol; 1978; 100():453-69. PubMed ID: 151497 [TBL] [Abstract][Full Text] [Related]
24. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer. Oh HJ; Park ES; Kang S; Jo I; Jung SC Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195 [TBL] [Abstract][Full Text] [Related]
26. Studies on experimentally induced hyperphenylalaninemia. Pueschel SM; Boylan J; Ellenbogen R J Ment Defic Res; 1988 Aug; 32 ( Pt 4)():309-19. PubMed ID: 2975336 [TBL] [Abstract][Full Text] [Related]
27. Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods. Reynolds R; Burri R; Herschkowitz N Exp Neurol; 1993 Dec; 124(2):357-67. PubMed ID: 7507064 [TBL] [Abstract][Full Text] [Related]
28. Comparative diagnostic value of phenylalanine challenge and phenylalanine hydroxylase activity in phenylketonuria. Hsieh MC; Berry HK; Bofinger MK; Phillips PJ; Guilfoile MB; Hunt MM Clin Genet; 1983 Jun; 23(6):415-21. PubMed ID: 6883786 [TBL] [Abstract][Full Text] [Related]
29. Evidence for central nervous system glial cell plasticity in phenylketonuria. Dyer CA; Kendler A; Philibotte T; Gardiner P; Cruz J; Levy HL J Neuropathol Exp Neurol; 1996 Jul; 55(7):795-814. PubMed ID: 8965095 [TBL] [Abstract][Full Text] [Related]
30. Proceedings: Atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment. Smith I; Lloyd J Arch Dis Child; 1974 Mar; 49(3):245. PubMed ID: 4856897 [No Abstract] [Full Text] [Related]
31. The effects of hyperphenylalaninemia on fetal development: a new animal model of maternal phenylketonuria. Brass CA; Isaacs CE; McChesney R; Greengard O Pediatr Res; 1982 May; 16(5):388-94. PubMed ID: 7201630 [TBL] [Abstract][Full Text] [Related]
32. In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Okano Y; Hase Y; Kawajiri M; Nishi Y; Inui K; Sakai N; Tanaka Y; Takatori K; Kajiwara M; Yamano T Pediatr Res; 2004 Nov; 56(5):714-9. PubMed ID: 15319459 [TBL] [Abstract][Full Text] [Related]
33. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice. Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172 [TBL] [Abstract][Full Text] [Related]
34. Relationship between myelin production and dopamine synthesis in the PKU mouse brain. Joseph B; Dyer CA J Neurochem; 2003 Aug; 86(3):615-26. PubMed ID: 12859675 [TBL] [Abstract][Full Text] [Related]
35. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats]. Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268 [TBL] [Abstract][Full Text] [Related]
36. Characterization of experimental phenylketonuria. Augmentation of hyperphenylalaninemia with alpha-methylphenylalanine and p-chlorophenylalanine. Lane JD; Schöne B; Langenbeck U; Neuhoff V Biochim Biophys Acta; 1980 Jan; 627(2):144-56. PubMed ID: 6444271 [TBL] [Abstract][Full Text] [Related]
37. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
38. Control of liver and brain aromatic amino-acid metabolism by phenylalanine hydroxylase. Tourian A Vopr Biokhim Mozga; 1973; 8():211-9. PubMed ID: 4281155 [No Abstract] [Full Text] [Related]
39. Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuria. Fiori E; Oddi D; Ventura R; Colamartino M; Valzania A; D'Amato FR; Bruinenberg V; van der Zee E; Puglisi-Allegra S; Pascucci T PLoS One; 2017; 12(8):e0183430. PubMed ID: 28850618 [TBL] [Abstract][Full Text] [Related]
40. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice. Mochizuki S; Mizukami H; Ogura T; Kure S; Ichinohe A; Kojima K; Matsubara Y; Kobayahi E; Okada T; Hoshika A; Ozawa K; Kume A Gene Ther; 2004 Jul; 11(13):1081-6. PubMed ID: 15057263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]